WXXWY:OTCMKTS
Wuxi Biologics Cayman ADR
12,48 USD
arrow_downward
-0,68%(-0,085) 1 d.
19. 10., 11:22:24 GMT-4 · USD
search
Všetky symboly
| Symbol | Cena | Zmena | % zmeny |
|---|
insights_autoGenerujú sa najdôležitejšie štatistiky pre WXXWY…
Otvoriť
12,19 USD
Vysoká
12,65 USD
Nízka
12,19 USD
Trh. kap.
198,43 mld.
Priem. obj.
64,29 tis.
Objem
6,54 tis.
Max. za 52 týž.
14,80 USD
Min. za 52 týž.
7,30 USD
Beta
0,01
Akcie v obehu
2,06 mld.
Počet zamestnancov
15 tis.
Otvoriť
12,19 USD
Vysoká
12,65 USD
Nízka
12,19 USD
Trh. kap.
198,43 mld.
Priem. obj.
64,29 tis.
Objem
6,54 tis.
Max. za 52 týž.
14,80 USD
Min. za 52 týž.
7,30 USD
Beta
0,01
Akcie v obehu
2,06 mld.
Počet zamestnancov
15 tis.
Spravodajstvo
Z internetových zdrojov a od spravodajských partnerov
Simply Wall Street
·
pred 20 minútami
Why Super Micro Computer Bears Were Right Before The Drop
MarketBeat
·
pred 15 minútami
Fox Factory (NASDAQ:FOXF) Shares Down 6.5% - Time to Sell?
Mahoning Matters
·
pred 33 minútami
S&P 500, Nasdaq climb as AI-linked stocks recover ahead of earnings
Profil
WuXi Biologics is a global Contract Research Development and Manufacturing Organization that provides open-access, integrated technology platforms for biologics drug development.
WuXi Biologics' roots date back to 2010, when it was founded as a division of WuXi AppTec and began building out capabilities and facilities required for biologics discovery, development and good manufacturing practices. After being spun off from its parent, WuXi Biologics went public on the Hong Kong Stock Exchange in June 2017.
As of 2021, WuXi Biologics has 18 manufacturing sites including ten in China, three in the United States, two in Ireland, two in Germany, and one in Singapore.
In August 2020, WuXi Biologics was selected to become a component of the Hang Seng Index in Hong Kong.
In January 2024, WuXi Biologics' share price fell on news that the United States Congress had introduced legislation to block any federal government contracts with the company due to national security concerns. The concerns stem from allegations, denied by the company, that it has worked closely with the People's Liberation Army as a part of the Chinese Communist Party's military-civil fusion strategy. Wikipedia
Informácie o subjekte Wuxi Biologics Cayman ADR
Generálny riaditeľZhisheng Chen
Zamestnanci14,7 tis.
Dátum založenia2010
Hlavné sídlo-
Odvetvie-